XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cashflows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2022
Cash Flows from Operating Activities          
Net increase (decrease) in net assets resulting from operations     $ 1,170,222 $ 6,673,266  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Origination and purchase of investments     (38,535,317) (113,532,124)  
Payment in-kind interest     (1,101,142) (324,906)  
Sales and repayments of investments $ 14,917,260 $ 53,173,229 46,998,760 120,043,899  
Net realized (gain) loss on investments 26,890,095 6,607,419 26,890,095 14,390,976  
Net change in unrealized appreciation/depreciation on investments (23,237,794) (4,747,787) (20,827,357) (14,637,324)  
Amortization of discount/premium on investments     (1,056,482) (2,118,211)  
Amortization of deferred debt issuance costs     520,000 447,778  
Amortization of original issue discount     53,333 53,333  
Net (increase) decrease in operating assets:          
Interest receivable     113,645 (45,077)  
Payment-in-kind interest receivable     (46,836) 40,751  
Receivable for investments sold     51,238 (16,027,641)  
Other receivables     (6,365) 0  
Prepaid expenses and other assets     (100,487) (159,782)  
Net increase (decrease) in operating liabilities:          
Payable for investments purchased     174,412 0  
Interest payable     1,384,062 1,374,887  
Directors fees payable     (7,150) (10,153)  
Accrued expenses and other liabilities     289,065 (253,867)  
Base management fees payable     (100,736) (37,882)  
Income-based incentive fees payable     (148,232) 0  
Net cash (used in) provided by operating activities     15,714,728 (4,122,077)  
Cash Flows from Financing Activities:          
Payment for deferred financing costs     0 (1,300,000)  
Issuance of common shares     0 3,141,576  
Distributions to stockholders     (8,610,939) (8,505,056)  
Repayments of Term loan     0 (102,000,000)  
Proceeds from borrowing on revolving financing facility     42,900,000 140,235,346  
Repayments of borrowing on revolving financing facility     (45,000,000) (32,485,346)  
Net cash (used in) provided by financing activities     (10,710,939) (913,480)  
Net change in cash     5,003,789 (5,035,557)  
Cash and restricted cash at beginning of year [1]     9,155,077 12,605,203 $ 12,605,203
Cash and restricted cash at end of period $ 14,158,866 [2] $ 7,569,646 [2] 14,158,866 [2] 7,569,646 [2] $ 9,155,077 [1]
Supplemental and non-cash financing cash flow information:          
Cash paid for interest     4,735,021 3,684,344  
Cash paid for taxes     294,330 270,618  
Issuance of shares pursuant to Dividend Reinvestment Plan     21,749 56,093  
Non-cash purchase of investments     (8,043,963) (2,903,400)  
Non-cash sale of investments     $ 8,043,963 $ 2,903,400  
[1] Represents $2,550,021 and $5,845,249 of unrestricted cash as of March 31, 2023 and March 31, 2022, respectively, and $6,605,056 and $6,759,954 of restricted cash for the same periods
[2] Represents $2,902,376 and $2,884,270 of unrestricted cash as of March 31, 2023 and March 31, 2022, respectively, and $11,256,490 and $4,685,376 of restricted cash for the same periods .